Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
Process for the production of Oxo-pregn-4-en-21,17-carbolactonen by metal free oxidation of 17-(3-hydroxypropyl)-3,17-dihydroxyandrostanes
No-Receipt date
2008-04225 - 06/11/2008
No-Filing date
20080402985 - 06/11/2008
No-Granting date
3067112 - 06/11/2008
No-EPO application date
05090214.7 - 21/07/2005
No-EPO granting date
1746101 - 06/08/2008
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
11/2008 - 19/12/2008
Expiration date
22/07/2025
Kind of title
Validation of European Patent
Legal status
NOT VALID
Priorities
-
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
C07J 53/00
Related Documents
Related Titles
Type
Master title
Related title
[ADD]
20140401616
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
410792
BAYER PHARMA AKTIENGESELLSCHAFT
MULLERSTRASSE 178
13353 BERLIN
GERMANY
Inventors
Code
Firstname
Surname
604758
SEILZ, CARSTEN
604759
SEBA, HARTMUT
Representatives
Code
Firstname
Surname
Address
Town
Zip
1602
AIKATERINI
SIOTOU
PATISION 122
ATHINA (ATTIKIS)
11257
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
4766
AIKATERINI
SIOTOU
PATISION (28IS OKTOVRIOU) 122
ATHINA (ATTIKIS)
11257
GREECE
Owners History
Date
Description
Comments
Data before modification
Data after modification
13/01/2012
Αλλαγή Επωνυμίας Δικαιούχου (7e801)
ΑΡ. ΠΡΩΤ. 6974/28-12-2011, ΚΩΔ. ΠΛΗΡ. 1602
257082 Bayer Schering Pharma Aktiengesellschaft Mullerstrasse 178 ΓΕΡΜΑΝΙΑ 13353 Berlin
410792 Bayer Pharma Aktiengesellschaft Mullerstrasse 178 ΓΕΡΜΑΝΙΑ 13353 Berlin
Title Instruments
Payments history
10 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).